|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
332,600,000 |
Market
Cap: |
64.20(B) |
Last
Volume: |
7,503,601 |
Avg
Vol: |
7,483,118 |
52
Week Range: |
$193.02 - $193.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bodine Chris W |
Director |
|
2013-12-13 |
4 |
S |
$159.66 |
$479,017 |
D/D |
(3,000) |
11,629 |
|
- |
|
Stewart Robert A |
Pres-Global Operations |
|
2013-12-09 |
4 |
S |
$166.02 |
$1,328,160 |
D/D |
(8,000) |
41,253 |
|
- |
|
Joyce R Todd |
CFO-Global |
|
2013-12-06 |
4 |
S |
$165.51 |
$2,421,061 |
I/I |
(14,600) |
40,000 |
|
- |
|
Turner Andrew L |
Director |
|
2013-12-05 |
4 |
S |
$162.43 |
$42,882 |
D/D |
(264) |
0 |
|
- |
|
Taylor Ronald R |
Director |
|
2013-12-02 |
4 |
S |
$163.01 |
$978,060 |
D/D |
(6,000) |
21,942 |
|
- |
|
Wilkinson George Fred |
PRES-ACTAVIS SPECIALTY BRANDS |
|
2013-11-27 |
4 |
S |
$165.00 |
$3,995,805 |
D/D |
(24,217) |
15,412 |
|
- |
|
Mayr Charles M |
Chief Communic Off-Global |
|
2013-11-26 |
4 |
S |
$162.60 |
$1,626,000 |
D/D |
(10,000) |
11,396 |
|
- |
|
Wilkinson George Fred |
PRES-ACTAVIS SPECIALTY BRANDS |
|
2013-11-25 |
4 |
S |
$165.00 |
$247,830 |
D/D |
(1,502) |
39,629 |
|
- |
|
Wilkinson George Fred |
PRES-ACTAVIS SPECIALTY BRANDS |
|
2013-11-22 |
4 |
S |
$165.00 |
$706,365 |
D/D |
(4,281) |
41,131 |
|
- |
|
Turner Andrew L |
Director |
|
2013-11-22 |
4 |
S |
$163.45 |
$408,625 |
D/D |
(2,500) |
264 |
|
- |
|
Stewart Robert A |
Pres-Global Operations |
|
2013-11-15 |
4 |
S |
$164.44 |
$1,644,400 |
D/D |
(10,000) |
49,253 |
|
- |
|
Weiss Fred G |
Director |
|
2013-11-14 |
4 |
S |
$164.15 |
$492,450 |
D/D |
(3,000) |
24,275 |
|
- |
|
Bisaro Paul |
Chair,Pres &CEO |
|
2013-11-11 |
4 |
S |
$158.48 |
$6,495,569 |
D/D |
(40,921) |
399,995 |
|
- |
|
Olafsson Sigurdur O |
PRES.-ACTAVIS PHARMA |
|
2013-11-11 |
4 |
S |
$159.87 |
$3,996,750 |
D/D |
(25,000) |
71,947 |
|
- |
|
Stewart Robert A |
Pres-Global Operations |
|
2013-11-11 |
4 |
S |
$158.39 |
$1,900,680 |
D/D |
(12,000) |
59,252 |
|
- |
|
Paonessa Albert Iii |
President Anda, Inc. |
|
2013-11-11 |
4 |
S |
$158.75 |
$1,031,875 |
D/D |
(6,500) |
27,229 |
|
- |
|
Buchen David A |
Chief Legal Officer-Global&Sec |
|
2013-11-11 |
4 |
S |
$159.30 |
$4,779,000 |
D/D |
(30,000) |
59,966 |
|
- |
|
King John A |
Director |
|
2013-11-08 |
4 |
S |
$155.41 |
$19,040,838 |
I/I |
(122,237) |
64,647 |
|
- |
|
King John A |
Director |
|
2013-11-07 |
4 |
S |
$156.43 |
$4,656,446 |
I/I |
(29,763) |
186,884 |
|
- |
|
King John A |
Director |
|
2013-11-07 |
4 |
S |
$156.38 |
$927,490 |
D/D |
(5,931) |
0 |
|
- |
|
Osullivan Patrick J |
Director |
|
2013-11-06 |
4 |
S |
$157.34 |
$550,690 |
D/D |
(3,500) |
2,270 |
|
- |
|
Howson Tamar D |
Director |
|
2013-11-06 |
4 |
S |
$157.34 |
$47,202 |
D/D |
(300) |
946 |
|
- |
|
Ebert Charles D |
SVP, BRANDS R&D |
|
2013-11-06 |
4 |
S |
$158.75 |
$1,726,724 |
D/D |
(10,877) |
7,611 |
|
- |
|
Joyce R Todd |
CFO-Global |
|
2013-11-06 |
4 |
S |
$158.42 |
$1,188,150 |
I/I |
(7,500) |
54,600 |
|
- |
|
Joyce R Todd |
CFO-Global |
|
2013-11-05 |
4 |
S |
$157.01 |
$2,355,150 |
I/I |
(15,000) |
62,100 |
|
- |
|
454 Records found
|
|
Page 17 of 19 |
|
|